Search Results 271-280 of 16845 for Antagonist
Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. Yaghi S. Shadi; Kamel H. Hooman; Elkind MS. Mitchell S V ...
... antagonism. Clin Sci (Lond). 1998 Aug; 95(2):195-202. View PubMed; Luchner A ... Chronic oral endothelin type A receptor antagonism in experimental heart failure.
TNFα Antagonists;. Active disease despite a history of at least one induction regimen of a TNFα Antagonist: Infliximab: Minimum induction regimen of 5 mg/kg ...
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
Furthermore, a maximal synergetic effect was achieved when a FAK inhibitor was given in combination with a PD-1 antagonist and chemotherapy in multiple pancreas ...
A cDNA encoding the interleukin-1 receptor antagonist (IL-1Ra) was delivered to the metacarpophalangeal joints in nine patients with rheumatoid arthritis.
buserelin, triptorelin) or LHRH antagonist (e.g. degarelix), anti-androgens (e.g., flutamide, bicalutamide, cyproterone acetate), estrogens (e.g., DES), or
... antagonist, and interleukin 5 receptor antagonist following endoscopic sinus surgery versus control in patient with chronic sinusitis with nasal polyps ...
CGRP antagonists. Also called Gepants, these medicines include atogepant (Qulipta) and rimegepant (Nurtec) and are approved for migraine prevention. Ask your ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.